Kaposi sarcoma in the setting of cushing disease

Endocr Pract. 2011 Jul-Aug;17(4):e87-91. doi: 10.4158/EP10355.CR.

Abstract

Objective: To report a case of a human immunodeficiency virus (HIV)-negative Kaposi sarcoma (KS) associated with Cushing disease (CD).

Methods: The details of case presentation, evaluation, diagnosis, and treatment are presented and cases of KS and CD published before November 1, 2010 on PubMed and Scopus are reviewed.

Results: A 54-year-old Hispanic HIV-negative man presented with typical signs and symptoms of CD (easy bruisability, proximal muscle wasting, and abdominal fat pads). Numerous raised, purplish, nonblanching plaques 0.5 to 2 cm in diameter extended throughout his lower extremities. Biochemical tests and pituitary magnetic resonance imaging confirmed CD. A lesion biopsy showed atypical vascular proliferation positive by immunohistochemistry for human herpesvirus 8 (HHV-8), consistent with KS. He underwent 2 transsphenoidal surgeries followed by a bilateral adrenalectomy. After recovery, his KS was treated with a systemic combination of liposomal doxorubicin and paclitaxel.

Conclusion: The occurrence of CD and KS is rare. Specific therapy for CD and chemotherapy for KS are effective in the treatment of KS associated with CD.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Doxorubicin / therapeutic use
  • Herpesvirus 8, Human / pathogenicity
  • Humans
  • Male
  • Middle Aged
  • Paclitaxel / therapeutic use
  • Pituitary ACTH Hypersecretion / diagnosis*
  • Pituitary ACTH Hypersecretion / virology
  • Sarcoma, Kaposi / diagnosis*
  • Sarcoma, Kaposi / virology

Substances

  • Antineoplastic Agents
  • Doxorubicin
  • Paclitaxel